Literature DB >> 23643150

Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression.

Tal Twito1, Zhiqi Chen, Ismat Khatri, Karrie Wong, David Spaner, Reg Gorczynski.   

Abstract

CD200, a membrane glycoprotein of the immunoglobulin superfamily, is overexpressed in CLL. Soluble in serum CD200 (sCD200) is correlated with poor prognosis in CLL. ADAM (a disintegrin and metalloproteinase) enzymes are implicated in membrane protein shedding. ADAM28 mRNA expression in CLL was correlated with plasma sCD200 levels, and release into culture from CLL cells. siRNA for ADAM28 decreased release of sCD200 from cultures and transfection of a cloned ADAM28 gene into CD200(+) cells enhanced release of sCD200. Our data support the hypothesis that ADAM28 plays a role in the shedding of CD200 from B-cell CLL cells.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23643150     DOI: 10.1016/j.leukres.2013.04.014

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  11 in total

1.  Tumor-derived vaccines containing CD200 inhibit immune activation: implications for immunotherapy.

Authors:  Zhengming Xiong; Elisabet Ampudia-Mesias; Rob Shaver; Craig M Horbinski; Christopher L Moertel; Michael R Olin
Journal:  Immunotherapy       Date:  2016-09       Impact factor: 4.196

2.  Membrane-associated and secreted forms of the Rhesus macaque rhadinovirus-encoded CD200 homologue and cellular CD200 demonstrate differential effects on Rhesus Macaque CD200 Receptor signaling and regulation of myeloid cell activation.

Authors:  Ryan D Estep; Aparna N Govindan; Kristin Fitzpatrick; Tiffany C Blair; S A Rahim Rezaee; David J Blackbourn; Scott W Wong
Journal:  J Virol       Date:  2020-12-16       Impact factor: 5.103

3.  Soluble CD200 Correlates With Interleukin-6 Levels in Sera of COPD Patients: Potential Implication of the CD200/CD200R Axis in the Disease Course.

Authors:  Priya Sakthivel; Angele Breithaupt; Marcus Gereke; David A Copland; Christian Schulz; Achim D Gruber; Andrew D Dick; Jens Schreiber; Dunja Bruder
Journal:  Lung       Date:  2016-11-18       Impact factor: 2.584

4.  CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.

Authors:  Elisabet Ampudia-Mesias; Francisco Puerta-Martinez; Miurel Bridges; David Zellmer; Andrew Janeiro; Matt Strokes; Yuk Y Sham; Ayman Taher; Maria G Castro; Christopher L Moertel; G Elizabeth Pluhar; Michael R Olin
Journal:  Neurotherapeutics       Date:  2021-04-07       Impact factor: 6.088

5.  Low expression of CD200 predicts shorter time-to-treatment in chronic lymphocytic leukemia.

Authors:  Yi Miao; Lei Fan; Yu-Jie Wu; Yi Xia; Chun Qiao; Yan Wang; Li Wang; Min Hong; Hua-Yuan Zhu; Wei Xu; Jian-Yong Li
Journal:  Oncotarget       Date:  2016-03-22

Review 6.  SheddomeDB: the ectodomain shedding database for membrane-bound shed markers.

Authors:  Wei-Sheng Tien; Jun-Hong Chen; Kun-Pin Wu
Journal:  BMC Bioinformatics       Date:  2017-03-14       Impact factor: 3.169

Review 7.  CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.

Authors:  Giovanni D'Arena; Vincenzo De Feo; Giuseppe Pietrantuono; Elisa Seneca; Giovanna Mansueto; Oreste Villani; Francesco La Rocca; Fiorella D'Auria; Teodora Statuto; Luciana Valvano; Francesca Arruga; Silvia Deaglio; Dimitar G Efremov; Alessandro Sgambato; Luca Laurenti
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

8.  The CD200-CD200R Axis Promotes Squamous Cell Carcinoma Metastasis via Regulation of Cathepsin K.

Authors:  Iasha Z Khan; Christina A Del Guzzo; Anqi Shao; Jiyoon Cho; Rong Du; Adrienne O Cohen; David M Owens
Journal:  Cancer Res       Date:  2021-06-28       Impact factor: 12.701

9.  Characterization of CD200 Ectodomain Shedding.

Authors:  Karrie K Wong; Fang Zhu; Ismat Khatri; Qiang Huo; David E Spaner; Reginald M Gorczynski
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

10.  Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.

Authors:  Michael R Olin; Elisabet Ampudia-Mesias; Christopher A Pennell; Aaron Sarver; Clark C Chen; Christopher L Moertel; Matthew A Hunt; G Elizabeth Pluhar
Journal:  Cancers (Basel)       Date:  2019-01-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.